US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

Takeda's diabetes drug fasiglifam shines in Phase III

Takeda's diabetes drug fasiglifam shines in Phase III

Benefits of Bayer acne drug backed for certain women

Benefits of Bayer acne drug backed for certain women

Lundbeck/Takeda's Brintellix improves depression symptoms

Lundbeck/Takeda's Brintellix improves depression symptoms

Sanofi stays in Toulouse...for now,

Sanofi stays in Toulouse...for now,

Pharma access problems "putting EU at risk"

Pharma access problems "putting EU at risk"

Weekly Market Movers (to 17 May 2013)

EvaluatePharma’s EventAnalyzer delivers a weekly global round up of key events driving company valuations.

Asco preview – Boehringer turns failure into a debatable win

One of the more bizarre studies to be presented at Asco concerns Boehringer Ingelheim’s lung cancer project nintedanib. A pivotal trial of the triple angiokinase inhibitor had failed a...

A*Star and Cytos advance Singapore's first flu vaccine

A*Star and Cytos advance Singapore's first flu vaccine

Sanofi to submit JAK inhibitor for MF

Sanofi to submit JAK inhibitor for MF

Bayer buys herbal drugmaker Steigerwald

Bayer buys herbal drugmaker Steigerwald
more news